Welcome to the CAR-T Resource Library

CAR-T (Chimeric Antigen Receptor-T cell) therapy is a new and exciting cellular immunotherapy with the potential to treat many cancers including chronic lymphocytic leukemia (CLL) and lymphomas.

It is the first FDA approved genetic therapy, the first “living drug” and involves removing and modifying a patient’s own white blood cells, then returning them to the patient’s body to fight their specific cancer.

Be sure to visit Dr. Brian Koffman’s CAR-T Blog!

The CAR-T Blog

Cytotoxic T Cells

Take Away Points: CLL is a cancer of our immune system so our ability to fight cancer is compromised and our...

CAR-T Part 2

Take Away Points: As the CAR-T technology improves, new targets for many cancers are being researched and identified. When the re-infused T...

CAR-T Part 1

Take Away Points: CAR-T (Chimeric Antigen Receptor T-cell) is a cellular immune therapy using our own T cells that have been...